EUVIMEDEUVIMED entdecken
Kohortenstudie

Retrospective cohort study on the efficacy and safety of high-intensity focused ultrasound in non-invasive treatment of uterine leiomyomas and adenomyosis

Zhan Su, Sha Liu, Jiulan Wang, Fengying Jin, Youjin Peng, Junjie Wen

Abdominal Radiology · 2025

DOI: 10.1007/s00261-025-04908-w ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Zhan Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guang'an People's Hospital, Guangan, China. Hauptthemen laut MEDLINE: Leiomyoma, Adenomyosis, Uterine Neoplasms, High-Intensity Focused Ultrasound Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Sichuan government Transfer payment project, Scientific and technological innovation guiding plan project of Guang'an, Guang'an People's Hospital High Quality Development Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the advantages of High-Intensity Focused Ultrasound (HIFU) in the treatment of uterine leiomyomas and adenomyosis. METHODS: Patients with uterine leiomyomas (435 cases) and adenomyosis (78 cases) treated in our hospital from March 2020 to October 2023 were selected to receive non-invasive treatment with HIFU. Clinical symptom improvement and fibroid shrinkage were observed, and the incidence of complications and adverse reactions during and after treatment were analyzed. RESULTS: The success rate of HIFU treatment in 435 cases of uterine leiomyomas was as high as 94.71%. The success rate of HIFU treatment was 96.15% in 78 cases of adenomyosis. Compared with before treatment, the improvement of clinical symptoms and the reduction of leiomyomas at one month, three months and six months after treatment were relatively better than those at the treatment period (P < 0.05). There were no serious adverse reactions in the patients during the treatment. CONCLUSION: The noninvasive application of HIFU on leiomyomas and adenomyosis effectively improves the clinical symptoms of patients, and the volume of fibroids decreases significantly. At the same time, HIFU is safe and worthy of clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaAdenomyosisUterine NeoplasmsHigh-Intensity Focused Ultrasound AblationHumansFemaleRetrospective StudiesAdultMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

AdenomyosisHigh intensity focused ultrasoundUterine leiomyomas

Autor:innen und Institutionen

  • Guang'an People's Hospital, Guangan, China.
  • Guang'an People's Hospital, Guangan, China. lrica147sci@163.com.

Förderung

  • Sichuan government Transfer payment project
  • Scientific and technological innovation guiding plan project of Guang'an
  • Guang'an People's Hospital High Quality Development Fund Project
  • Scientific and technological innovation guiding plan project of Guang’an

Zitieren

APA

Su, Z., Liu, S., Wang, J., Jin, F., Peng, Y., & Wen, J. (2025). Retrospective cohort study on the efficacy and safety of high-intensity focused ultrasound in non-invasive treatment of uterine leiomyomas and adenomyosis. Abdominal Radiology. https://doi.org/10.1007/s00261-025-04908-w

Vancouver

Su Z, Liu S, Wang J, Jin F, Peng Y, Wen J. Retrospective cohort study on the efficacy and safety of high-intensity focused ultrasound in non-invasive treatment of uterine leiomyomas and adenomyosis. Abdominal Radiology. 2025. doi:10.1007/s00261-025-04908-w

BibTeX
@article{Su2025,
  author = {Su, Zhan and Liu, Sha and Wang, Jiulan and Jin, Fengying and Peng, Youjin and Wen, Junjie},
  title = {Retrospective cohort study on the efficacy and safety of high-intensity focused ultrasound in non-invasive treatment of uterine leiomyomas and adenomyosis},
  journal = {Abdominal Radiology},
  year = {2025},
  doi = {10.1007/s00261-025-04908-w}
}
Kostenlos starten →